Figure 5. The correlation between H19 expression level and clinical characteristics of glioma patients by Oncomine. (A) Comparison of the expression level of H19 in men and women. (B) Comparison of the expression level of H19 in patients alive or dead after one year. (C) The expression level of H19 in patients with MGMT methylation negative was lower than that in patients with MGMT methylation positive. (D) The expression of H19 elevated with the increase of staging. (E, F) H19 expression in serum-free cultured glioma cells was higher than that in serum cultured glioma cells. Abbreviations: NA, No value; NBE, Serum-free culture.